{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:22:35Z","timestamp":1766269355560,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00228-021-03126-9","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T05:02:46Z","timestamp":1617426166000},"page":"1357-1368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Population pharmacokinetic model of subcutaneous fentanyl in older acute care patients"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4284-0265","authenticated-orcid":false,"given":"Aymen A.","family":"Al-Qurain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Upton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"issue":"3","key":"3126_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/00000542-200409000-00023","volume":"101","author":"ED Kharasch","year":"2004","unstructured":"Kharasch ED, Hoffer C, Whittington D (2004) Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate. Anesthesiology 101(3):738\u2013743","journal-title":"Anesthesiology"},{"issue":"3 Suppl 1","key":"3126_CR2","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jpain.2010.11.006","volume":"12","author":"FM Gloth 3rd","year":"2011","unstructured":"Gloth FM 3rd (2011) Pharmacological management of persistent pain in older persons: focus on opioids and nonopioids. J Pain 12(3 Suppl 1):S14\u2013S20","journal-title":"J Pain"},{"issue":"4","key":"3126_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40266-019-00742-0","volume":"37","author":"AA Al-Qurain","year":"2020","unstructured":"Al-Qurain AA, Gebremichael LG, Khan MS, Williams DB, Mackenzie L, Phillips C, Russell P, Roberts MS, Wiese MD (2020) Prevalence and factors associated with analgesic prescribing in poly-medicated elderly patients. Drugs Aging 37(4):291\u2013300","journal-title":"Drugs Aging"},{"issue":"5 Suppl","key":"3126_CR4","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.jpainsymman.2005.01.009","volume":"29","author":"TH Stanley","year":"2005","unstructured":"Stanley TH (2005) Fentanyl. J Pain Symptom Manag 29(5 Suppl):S67\u2013S71","journal-title":"J Pain Symptom Manag"},{"key":"3126_CR5","doi-asserted-by":"crossref","unstructured":"Macintyre PE, Schug SA (2014) Acute pain management: a practical guide. Crc Press","DOI":"10.1201\/b17905"},{"issue":"8","key":"3126_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2165\/00003088-200645080-00006","volume":"45","author":"M Danvish","year":"2006","unstructured":"Danvish M, Kirby M, Robertson P, Hellriegel E, Jiang JG (2006) Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics. Clin Pharmacokinet 45(8):843\u2013850","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3126_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00228-007-0444-8","volume":"64","author":"K Moksnes","year":"2008","unstructured":"Moksnes K, Fredheim OM, Klepstad P, Kaasa S, Angelsen A, Nilsen T, Dale O (2008) Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference? Eur J Clin Pharmacol 64(5):497\u2013502","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3126_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/EJA.0b013e328331a361","volume":"27","author":"SJ Capper","year":"2010","unstructured":"Capper SJ, Loo S, Geue JP, Upton RN, Ong J, Macintyre PE, Ludbrook GL (2010) Pharmacokinetics of fentanyl after subcutaneous administration in volunteers. Eur J Anaesthesiol 27(3):241\u2013246","journal-title":"Eur J Anaesthesiol"},{"issue":"2","key":"3126_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/bja\/81.2.152","volume":"81","author":"JP Thompson","year":"1998","unstructured":"Thompson JP, Bower S, Liddle AM, Rowbotham DJ (1998) Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. Br J Anaesth 81(2):152\u2013154","journal-title":"Br J Anaesth"},{"issue":"2","key":"3126_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1521-6896(03)00002-8","volume":"17","author":"MR Sadean","year":"2003","unstructured":"Sadean MR, Glass PS (2003) Pharmacokinetics in the elderly. Best Pract Res Clin Anaesthesiol 17(2):191\u2013205","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"4","key":"3126_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345\u2013351","journal-title":"Am J Geriatr Pharmacother"},{"key":"3126_CR12","doi-asserted-by":"crossref","unstructured":"Al-Qurain A, Gebremichael L, Khan M, Williams D, Mackenzie L, Phillips C, Russell P, Roberts M, Wiese M (2020) Opioid prescribing and risk of drug-opioid interactions in elderly discharged patients with polypharmacy in Australia. Manuscript submitted for publication","DOI":"10.1007\/s11096-020-01191-1"},{"issue":"9868","key":"3126_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752\u2013762","journal-title":"Lancet"},{"issue":"5","key":"3126_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.18773\/austprescr.2017.055","volume":"40","author":"SN Hilmer","year":"2017","unstructured":"Hilmer SN, Gnjidic D (2017) Prescribing for frail older people. Aust Prescr 40(5):174\u2013178","journal-title":"Aust Prescr"},{"issue":"3","key":"3126_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2125.2010.03847.x","volume":"71","author":"AJ McLachlan","year":"2011","unstructured":"McLachlan AJ, Bath S, Naganathan V, Hilmer SN, Le Couteur DG, Gibson SJ, Blyth FM (2011) Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol 71(3):351\u2013364","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3126_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bcp.13873","volume":"85","author":"JH Hughes","year":"2019","unstructured":"Hughes JH, Phelps MA, Upton RN, Reuter SE, Gao Y, Byrd JC, Grever MR, Hofmeister CC, Marcucci G, Blum W, Blum KA, Foster DJR (2019) Population pharmacokinetics of lenalidomide in patients with B cell malignancies. Br J Clin Pharmacol 85(5):924\u2013934","journal-title":"Br J Clin Pharmacol"},{"key":"3126_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fnagi.2016.00144","volume":"8","author":"M Prostran","year":"2016","unstructured":"Prostran M, Vujovic KS, Vuckovic S, Medic B, Srebro D, Divac N, Stojanovic R, Vujovic A, Jovanovic L, Jotic A, Cerovac N (2016) Pharmacotherapy of pain in the older population: the place of opioids. Front Aging Neurosci 8:144","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3126_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/CCM.0000000000001347","volume":"44","author":"L Choi","year":"2016","unstructured":"Choi L, Ferrell BA, Vasilevskis EE, Pandharipande PP, Heltsley R, Ely EW, Stein CM, Girard TD (2016) Population pharmacokinetics of fentanyl in the critically Ill. Crit Care Med 44(1):64\u201372","journal-title":"Crit Care Med"},{"issue":"2","key":"3126_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/15360288.2012.679725","volume":"26","author":"H Kokubun","year":"2012","unstructured":"Kokubun H, Ebinuma K, Matoba M, Takayanagi R, Yamada Y, Yago K (2012) Population pharmacokinetics of transdermal fentanyl in patients with cancer-related pain. J Pain Palliat Care Pharmacother 26(2):98\u2013104","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"7","key":"3126_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1177\/00912700122010663","volume":"41","author":"RE Ariano","year":"2001","unstructured":"Ariano RE, Duke PC, Sitar DS (2001) Population pharmacokinetics of fentanyl in healthy volunteers. J Clin Pharmacol 41(7):757\u2013763","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"3126_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00228-015-2005-x","volume":"72","author":"AW Oosten","year":"2016","unstructured":"Oosten AW, Abrantes JA, Jonsson S, de Bruijn P, Kuip EJ, Falcao A, van der Rijt CC, Mathijssen RH (2016) Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients. Eur J Clin Pharmacol 72(4):459\u2013467","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3126_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31\u201341","journal-title":"Nephron"},{"issue":"5","key":"3126_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"2","key":"3126_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1532-5415.2004.52073.x","volume":"52","author":"N Dendukuri","year":"2004","unstructured":"Dendukuri N, McCusker J, Belzile E (2004) The identification of seniors at risk screening tool: further evidence of concurrent and predictive validity. J Am Geriatr Soc 52(2):290\u2013296","journal-title":"J Am Geriatr Soc"},{"key":"3126_CR25","unstructured":"Flockhart D (2007) Drug interactions: cytochrome P450 drug interaction table. In: ed. Indiana University School of Medicine."},{"key":"3126_CR26","unstructured":"Medicine So (2018) P450 Drug interactions, abbreviated \u201cClinically Relevant\u201d table. In: ed. INDIANA UNIVERSITY."},{"key":"3126_CR27","unstructured":"Handbook AM (2017) Australian medicines handbook AUSTRALIAN MEDICINES HAND."},{"key":"3126_CR28","doi-asserted-by":"crossref","unstructured":"Al-Qurain A, Williams D, Mackenzie L, Roberts M, Wiese M (2020) Simultaneous LC-MS\/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetric absorptive micro sampling. Manuscript submitted for publication","DOI":"10.1016\/j.jpba.2021.114171"},{"issue":"4","key":"3126_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/psp.2013.14","volume":"2","author":"D Mould","year":"2013","unstructured":"Mould D, Upton RN (2013) Basic concepts in population modeling, simulation, and model-based drug development\u2014part 2: introduction to pharmacokinetic modeling methods. CPT Pharmacometrics Syst Pharmacol 2(4):1\u201314","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6","key":"3126_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.burns.2008.12.006","volume":"35","author":"K Kaneda","year":"2009","unstructured":"Kaneda K, Han TH (2009) Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns. Burns 35(6):790\u2013797","journal-title":"Burns"},{"issue":"3","key":"3126_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/clpt.2011.133","volume":"90","author":"SJ Jin","year":"2011","unstructured":"Jin SJ, Jung JY, Noh MH, Lee SH, Lee EK, Choi BM, Song MH, Noh GJ (2011) The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation. Clin Pharmacol Ther 90(3):423\u2013431","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3126_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0897190007304657","volume":"20","author":"LC Hutchison","year":"2007","unstructured":"Hutchison LC, O'Brien CE (2007) Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Pract 20(1):4\u201312","journal-title":"J Pharm Pract"},{"issue":"3","key":"3126_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/00000542-199909000-00020","volume":"91","author":"KT Olkkola","year":"1999","unstructured":"Olkkola KT, Palkama VJ, Neuvonen PJ (1999) Ritonavir\u2019s role in reducing fentanyl clearance and prolonging its half-life. Anesthesiology 91(3):681\u2013685","journal-title":"Anesthesiology"},{"issue":"2","key":"3126_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U (2009) Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41(2):67\u201376","journal-title":"Drug Metab Rev"},{"issue":"6","key":"3126_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/11631760-000000000-00000","volume":"29","author":"M Petrovic","year":"2012","unstructured":"Petrovic M, van der Cammen T, Onder G (2012) Adverse drug reactions in older people: detection and prevention. Drugs Aging 29(6):453\u2013462","journal-title":"Drugs Aging"},{"issue":"8","key":"3126_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","volume":"38","author":"K Turnheim","year":"2003","unstructured":"Turnheim K (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38(8):843\u2013853","journal-title":"Exp Gerontol"},{"issue":"3A","key":"3126_CR37","first-page":"A593","volume":"69","author":"J Varvel","year":"1988","unstructured":"Varvel J, Shafer S, Hwang S, Coen P, Stanski D (1988) Bioavailability and absorption of transdermal fentanyl. Anesthesiol J Am Soc Anesthesiol 69(3A):A593\u2013A593","journal-title":"Anesthesiol J Am Soc Anesthesiol"},{"issue":"3","key":"3126_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bpa.2011.06.003","volume":"25","author":"JC Coldrey","year":"2011","unstructured":"Coldrey JC, Upton RN, Macintyre PE (2011) Advances in analgesia in the older patient. Best Pract Res Clin Anaesthesiol 25(3):367\u2013378","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"10","key":"3126_CR39","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1345\/aph.1L168","volume":"42","author":"D Foster","year":"2008","unstructured":"Foster D, Upton R, Christrup L, Popper L (2008) Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Ann Pharmacother 42(10):1380\u20131387","journal-title":"Ann Pharmacother"},{"issue":"6","key":"3126_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/bja\/60.6.619","volume":"60","author":"MA Singleton","year":"1988","unstructured":"Singleton MA, Rosen JI, Fisher DM (1988) Pharmacokinetics of fentanyl in the elderly. Br J Anaesth 60(6):619\u2013622","journal-title":"Br J Anaesth"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03126-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T07:07:48Z","timestamp":1628233668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03126-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3126"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03126-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Central Adelaide Local Health Network ethics committee and University of South Australia Human Ethics Committee. This study was approved by the Human Research Ethics Committee of the Central Adelaide Local Health Network (R20190105) and the Human Ethics Committee at University of South Australia (202316).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants were deidentified or anonymous.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}